Abacus Global Management, Inc. (ABL)
NASDAQ: ABL · Real-Time Price · USD
5.29
-0.12 (-2.22%)
At close: Aug 1, 2025, 4:00 PM
5.14
-0.15 (-2.84%)
After-hours: Aug 1, 2025, 6:47 PM EDT
Blueprint Medicines Stock Forecast
Stock Price Forecast
The 4 analysts that cover Blueprint Medicines stock have a consensus rating of "Strong Buy" and an average price target of $13.13, which forecasts a 148.20% increase in the stock price over the next year. The lowest target is $10 and the highest is $15.
Price Target: $13.13 (+148.20%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Jul 2, 2025.
Analyst Ratings
The average analyst rating for Blueprint Medicines stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $12 → $10 | Buy | Maintains | $12 → $10 | +89.04% | Jul 2, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $12 → $12 | Buy | Maintains | $12 → $12 | +126.84% | May 9, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $13 → $12 | Buy | Maintains | $13 → $12 | +117.39% | Apr 8, 2025 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $17 → $15 | Strong Buy | Maintains | $17 → $15 | +183.55% | Jan 7, 2025 |
| B. Riley Securities | B. Riley Securities | Strong Buy Maintains $16 → $17 | Strong Buy | Maintains | $16 → $17 | +221.36% | Nov 25, 2024 |
Financial Forecast
Revenue This Year
189.19M
from 111.92M
Increased by 69.03%
Revenue Next Year
239.75M
from 189.19M
Increased by 26.72%
EPS This Year
0.77
from -0.34
EPS Next Year
0.97
from 0.77
Increased by 26.21%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 |
|---|---|---|
| High | 208.9M | 267.7M |
| Avg | 189.2M | 239.8M |
| Low | 177.5M | 223.4M |
Revenue Growth
| Revenue Growth | 2025 | 2026 |
|---|---|---|
| High | 86.6% | 41.5% |
| Avg | 69.0% | 26.7% |
| Low | 58.6% | 18.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 0.86 | 1.07 | 1.10 |
| Avg | 0.77 | 0.97 | 1.06 |
| Low | 0.73 | 0.83 | 1.03 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | 39.9% | 14.1% |
| Avg | - | 26.2% | 9.8% |
| Low | - | 8.8% | 6.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.